Jobs / United States / Novartis Pharmaceuticals Corporation
Value & Access TA Head Immunology & Neuroscience, APMA
Novartis Pharmaceuticals Corporation · 🇺🇸 Mapletree Business City (MBC)
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles2 certified filings for “Director - Decision Science, Immunology Product Lead” (Molecular and Cellular Biologists) in NJ: $96k–$138k, median $117k. Most were filed at wage level II (50%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary Value & Access TA Head Immunology & Neuroscience, APMA Location : Singapore #LI-Hybrid Are you an experienced Value & Access leader ready to shape sustainable patient access across diverse healthcare systems? We are looking for a strategic, collaborative leader to drive regional V&A execution for an assigned Therapeutic Area across Asia Pacific Middle East Africa (APMA) markets. As Region V&A Therapeutic Area Head, you will translate international strategies into locally relevant access plans, influence asset-level strategy through Integrated Product Access Teams, and enable countries to secure timely, sustainable, and value-based patient access. You will lead access readiness, pricing and lifecycle inputs, performance improvement, and cross-country collaboration while partnering closely with Medical, Commercial, Corporate/Public Affairs, Finance, Regulatory, and other functions. Job Description Major Accountabilities: • Shape and execute V&A strategy: Drive Therapeutic Area access strategies across the region, align international direction with country needs, and guide markets through access challenges and opportunities. • Lead launch readiness: Own the V&A contribution to Launch Readiness Reviews, ensure high-quality deliverables, and coordinate cross-functional risk identification, action planning, and follow-through. • Accelerate access performance: Use dashboards, analytics, Execution Excellence, and Access360 insights to identify high-impact opportunities, strengthen payer engagement, and scale cross-country learning. • Influence pricing decisions: Provide regional input on pricing assumptions, profitability, competitive benchmarks, gross-to-net implications, business cases, and cross-country pricing decisions. • Shape the external environment: Partner with Public Affairs and other stakeholders to address market access barriers, strengthen reimbursement pathways, monitor policy developments, and support healthcare-system readiness. • Build regional capability: Develop tools, training, frameworks, and communities of practice across pricing, negotiation, HEOR, HTA, evidence generation, and access execution. • Lead through collaboration: Unite regional and country teams, foster an inclusive and high-performing culture, support talent development, and role-model ethics, compliance, and an enterprise mindset. Requirements • An advanced degree in life sciences, health economics, public health, business administration, or a related field; an MBA is an advantage. • At least 15 years of pharmaceutical industry experience, including significant leadership responsibility in market access, pricing, reimbursement, health policy, or a closely related discipline. • A strong record of developing and executing access strategies, leading cross-functional teams, and influencing effectively in a complex matrix environment. • Experience engaging payers, health technology assessment bodies, health authorities, and other external stakeholders. • Deep understanding of pricing, reimbursement, evidence requirements, scenario planning, contracting, value communication, and healthcare-system dynamics. • International or above-country experience across multiple markets or regions; country V&A experience and relevant Therapeutic Area expertise are strongly preferred. • The ability to translate complex access challenges and analytics into clear strategies, decisions, and measurable performance improvements. • Commercial or profit-and-loss experience would be an added advantage. Skills Desired Business Acumen, Cross-Functional Collaboration, Cross-Functional Leadership, Employee Development, Health Economics, Health Technology Assessment (HTA), Influencing Skills, Innovation, Inspirational Leadership, Patient